ATXS Astria Therapeutics Inc Total Asset Value of Company
Astria Therapeutics (ATXS) is expanding its presence in the targeted therapy segment for rare pathologies, focusing on the launch of an innovative antibody. The business relies on a closed biopharmaceutical environment that ensures high physician loyalty. The market trend for total assets stands at 316.73. The brand's high authority among patients is evidenced by its commitment to scientific research, enabling the company to effectively transform treatment approaches for severe genetic disorders.
Analytical breakdowns and data insights for company Astria Pharma (ATXS)
- current quotes and average value forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Astria Therapeutics|ATXS - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Astria Corp|ATXS - Company Aggregate Debts|Debts to Book Capitalization Astria Corp|ATXS - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Astria Therapeutics|Interim Coverage Ratio astriatx.com
- net income and valuation multiples indicators:
Fundamental valuation:Astria Therapeutics
Total assets reflect the aggregate of resources and liabilities, calculated reversely via daily ROA to assess fundamental value. This trend discounts market expectations regarding capital efficiency. By analyzing the total asset volume, an investor determines the company's ability to fund R&D. For Astria Therapeutics (ATXS), this is critically important when navigating FDA stages amidst fierce patent competition.
Key competitors
ARGX - Company Total Asset Base|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|Savara Corp - Company Total Assets|RIGL - Company Total Assets|AnaptysBio, Inc. (ANAB) - Aggregate Company Assets|ENGN - Company Total Asset Base|Cumulative Company Assets RAPT|JBIO (Aerovate) - Aggregate Business Assets|Aggregate Company Assets Aclaris (ACRS)|KYTX (Kyverna Therapeutics, Inc) - Aggregate Asset Value|Company Total Assets TLSA (Tiziana Life Sciences)|Company Total Asset Base cabalettabio.com (CABA)|Ventyx Biosciences, Inc. - Company Total Assets|THTX - Company Total Assets|AVTX (Avalo Therapeutics Inc.) - Cumulative Company Assets|Eledon Pharmaceuticals, Inc - Aggregate Asset Value|Cumulative Company Assets AGEN|CLYM (climbbio.com) - Aggregate Business Assets|Company Total Assets ZURA|ATYR (aTyr Pharma Inc) - Aggregate Asset Value|Company Total Assets ADAG (Adagene Inc.)|ImageneBio (IMA) - Company Assets|STTK - Aggregate Company Assets|Aggregate Asset Value EQ (Equillium, Inc.)|CNTB: Company Total Assets|Immunic (IMUX) - Company Total Assets|Aggregate Company Assets Atara Biotherapeutics, Inc.|InflaRx GmbH - Total Asset Value of Company|Company Total Assets XFOR|ACET - Company Assets|Celularity - Cumulative Company Assets|Company Total Assets INmune Bio Inc INMB|BRNS: Cumulative Company Assets|Kezar Life Sciences Inc - Aggregate Business Assets|SABS: Company Total Assets|AKTX - Company Total Asset Base|ENLV (Enlivex Therapeutics Ltd) - Company Total Assets|Cumulative Company Assets Q32 Bio Corp (QTTB)|Aggregate Company Assets GeoVax Labs Inc (GOVX)|Company Total Asset Base Edesa Biotech Corp|Company Total Assets IBIO (iBio, Inc.)|Company Total Assets Carisma Therapeutics Inc CARM|XTLB: Cumulative Company Assets|Bolt Biotherapeutics - Aggregate Business Assets|HCWB (hcwbiologics.com) - Cumulative Company Assets|Total Business Assets APVO|Aggregate Company Assets AIM ImmunoTech Inc.|Aditxt Corp (ADTX) - Company Total Asset Base|Aggregate Company Assets GRI Bio (GRI)|XRTX: Total Asset Value of Company|Company Total Assets HIND (ReShape Lifesciences)|Aggregate Asset Value REVB|Indaptus Therapeutics - Company Total Assets|SCNI - Company Total Assets|calcimedica.com (CALI) - Aggregate Company Assets|Affimed N.V. - Aggregate Asset Value|Aggregate Company Assets Allakos Inc|Cumulative Company Assets HOOKIPA (HOOK)|Company Total Assets IGMS|Company Total Assets iteostherapeutics.com (ITOS)|Ocean Biomedical - Cumulative Company Assets|Aggregate Asset Value TCBP|Third Harmonic Bio, Inc - Company Total Assets